Viatris Inc. (LON:0A5V)

London flag London · Delayed Price · Currency is GBP · Price in USD
7.59
+0.16 (2.14%)
At close: Apr 17, 2025
-32.72%
Market Cap 7.02B
Revenue (ttm) 11.77B
Net Income (ttm) -506.58M
Shares Out n/a
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend 0.37 (4.93%)
Ex-Dividend Date Mar 10, 2025
Volume 4,447
Average Volume 7,945
Open 7.42
Previous Close 7.43
Day's Range 7.40 - 7.62
52-Week Range 7.89 - 10.81
Beta n/a
RSI 42.50
Earnings Date May 8, 2025

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN... [Read more]

Industry Pharmaceutical Preparations
Founded 1961
Employees 32,000
Stock Exchange London Stock Exchange
Ticker Symbol 0A5V
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.